Taking blood apart by sound
The project aims to develop an acoustic separation technology for blood components to improve resolution, efficiency, and quality in healthcare applications, ultimately facilitating market integration.
Projectdetails
Introduction
Separation of blood components is of high importance in healthcare and often requires fractionation of blood into its subcomponents by centrifugation. There are several scenarios that call for improved resolution:
Scenarios for Improved Resolution
- When blood is drawn from a donor and a specific cell type is extracted while returning remaining blood components.
- In cancer immunotherapy where T-cells are isolated from the blood and then genetically reprogrammed to be re-infused in the patient, where they seek out and destroy cancer cells.
- Circulating tumor cells, which are involved in the process of formation of metastases in cancer patients, can be detected and monitored by extracting cancer cells in large volumes of blood.
- Improving the quality and reducing the number of manual procedures in diagnostic instrumentation that analyzes blood.
Limitations of Centrifugation
Centrifugation has the fundamental drawback of having rotating parts, thereby taking up space and being difficult to implement for flow-through processing. This is desirable both for integration in analytical equipment and for processing blood for continuous re-infusion into a person.
Alternative Approach
We will investigate an alternative to centrifugation wherein blood components are separated by a sound field. Cells will be separated based on differences in density and size while flowing through an acoustic separator module. Recent ERC-funded research indicates that this approach is feasible, but three scientific questions have been identified with fundamental impact on the commercial potential of this technology:
- How selectively can sub-groups of blood cells be separated by acoustic separation?
- Can acoustic separation be scaled for high throughput applications?
- Can acoustic separation affect blood cells?
Project Goals
To address these questions, my team will design and build two prototype systems for whole blood processing and evaluate the quality and throughput of the separation, with the ultimate goal of bringing this technology to the market for the benefit of society.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 150.000 |
Totale projectbegroting | € 150.000 |
Tijdlijn
Startdatum | 1-5-2023 |
Einddatum | 31-10-2024 |
Subsidiejaar | 2023 |
Partners & Locaties
Projectpartners
- LUNDS UNIVERSITETpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Acoustic whole blood imaging flow cytometry for rare cell identificationThis project aims to develop acoustic whole-blood cytometry for accurate detection and monitoring of circulating tumor cells in metastatic breast and prostate cancer, enhancing personalized healthcare. | ERC Proof of... | € 150.000 | 2024 | Details |
Single-Molecule Acousto-Photonic NanofluidicsSIMPHONICS aims to develop a high-throughput, non-invasive platform for protein fingerprinting by integrating nanopore technology with acoustic manipulation and fluorescence detection. | ERC Starting... | € 1.499.395 | 2022 | Details |
Next-generation red cell analysers for blood-banking, transfusion medicine, and haematological diagnosisDeveloping a single-cell oxygen saturation imaging method to measure O2 release from red blood cells, aiming to enhance blood quality assessment and clinical applications in transfusion medicine. | ERC Proof of... | € 150.000 | 2024 | Details |
Adaptive Separation using Dynamic Nanofibril NetworksThis project aims to develop tunable nanofibril networks for adaptive separation technologies, enhancing selectivity and throughput in pharmaceutical applications. | ERC Starting... | € 1.488.854 | 2025 | Details |
Reliable and scalable procedures for the isolation and loading of extracellular vesiclesLABORIOUS aims to develop innovative methods for isolating and loading therapeutic agents into exosomes, enhancing their clinical application in various diseases while minimizing membrane damage. | ERC Proof of... | € 150.000 | 2024 | Details |
Acoustic whole blood imaging flow cytometry for rare cell identification
This project aims to develop acoustic whole-blood cytometry for accurate detection and monitoring of circulating tumor cells in metastatic breast and prostate cancer, enhancing personalized healthcare.
Single-Molecule Acousto-Photonic Nanofluidics
SIMPHONICS aims to develop a high-throughput, non-invasive platform for protein fingerprinting by integrating nanopore technology with acoustic manipulation and fluorescence detection.
Next-generation red cell analysers for blood-banking, transfusion medicine, and haematological diagnosis
Developing a single-cell oxygen saturation imaging method to measure O2 release from red blood cells, aiming to enhance blood quality assessment and clinical applications in transfusion medicine.
Adaptive Separation using Dynamic Nanofibril Networks
This project aims to develop tunable nanofibril networks for adaptive separation technologies, enhancing selectivity and throughput in pharmaceutical applications.
Reliable and scalable procedures for the isolation and loading of extracellular vesicles
LABORIOUS aims to develop innovative methods for isolating and loading therapeutic agents into exosomes, enhancing their clinical application in various diseases while minimizing membrane damage.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Fully automated cell-free DNA extraction and quantification - liquid biopsies safely from Patient to LabBiopSense aims to develop and validate a fully automated disposable cartridge for cfDNA extraction from blood, enhancing reliability and transport ease for cancer diagnostics and prenatal screening. | EIC Transition | € 2.500.000 | 2022 | Details |
Acoustofluidic thin-film actuated chip for exosome separation from bloodAcouSome aims to develop a polymer-based microfluidic chip for isolating exosomes from blood using advanced acoustofluidics, enhancing point-of-care diagnostics for various diseases. | EIC Transition | € 2.498.419 | 2023 | Details |
Wie het kleine niet eert...Het project richt zich op het ontwikkelen van een efficiëntere EC-scheidingsinstallatie voor non-ferro metalen uit bodemas, met als doel een jaarlijkse CO2-besparing van 11.000 ton en verhoogde metaalterugwinning. | Demonstratie... | € 337.280 | 2019 | Details |
Torus bloedkoelerTorus Cooling onderzoekt de haalbaarheid van een innovatieve bloedkoeler voor duurzaam en sanitair transport van slachtbloed. | Mkb-innovati... | € 20.000 | 2021 | Details |
De eerste circulair geproduceerde bloedafnamebuisLabonovum ontwikkelt Hem-Col-Circ, een circulaire bloedafnameoplossing die de medische afvalimpact vermindert door innovatieve materialen en processen te onderzoeken voor duurzame bloedafname. | Mkb-innovati... | € 20.000 | 2021 | Details |
Fully automated cell-free DNA extraction and quantification - liquid biopsies safely from Patient to Lab
BiopSense aims to develop and validate a fully automated disposable cartridge for cfDNA extraction from blood, enhancing reliability and transport ease for cancer diagnostics and prenatal screening.
Acoustofluidic thin-film actuated chip for exosome separation from blood
AcouSome aims to develop a polymer-based microfluidic chip for isolating exosomes from blood using advanced acoustofluidics, enhancing point-of-care diagnostics for various diseases.
Wie het kleine niet eert...
Het project richt zich op het ontwikkelen van een efficiëntere EC-scheidingsinstallatie voor non-ferro metalen uit bodemas, met als doel een jaarlijkse CO2-besparing van 11.000 ton en verhoogde metaalterugwinning.
Torus bloedkoeler
Torus Cooling onderzoekt de haalbaarheid van een innovatieve bloedkoeler voor duurzaam en sanitair transport van slachtbloed.
De eerste circulair geproduceerde bloedafnamebuis
Labonovum ontwikkelt Hem-Col-Circ, een circulaire bloedafnameoplossing die de medische afvalimpact vermindert door innovatieve materialen en processen te onderzoeken voor duurzame bloedafname.